SUMM.L Share News (SUMM)

UK drug discovery company Summit has signed a technology licensing agreement with US pharmaceuticals colossus, Bristol-Myers Squibb.The US firm will use use Summit's proprietary Seglin technology to identify and develop drug candidates for up to ten targets across multiple therapeutic areas. Summit will receive a $100,000 technology access fee and is eligible for research, development and regulatory milestones of up to $30m per product, plus royalties on worldwide sales of products arising from the technology.Pinnacle Technology Group, the AIM listed provider of cloud based technology solutions, has reminded the world that it was heavily and profitably involved in broadcasts of the Olympic & Paralympic Games in London. In total, Pinnacle supplied services to 31 countries, which included Brazilian broadcasters Globosat and Globo Sports. Brazil will host the 2016 Olympic and Paralympic Games.Eckoh, the provider of speech recognition and associated payment solutions, has been awarded a three year contract with international services company Serco to provide hosted speech recognition services to a client within central government. It is the company's first contract win with Serco, one of the UK's leading outsourcing firms. JH